Gene · 135152
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 3,3'-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. | Cancer Cell Int | 2023 | 37633886 | PubTator, text mining | PubMed |
| Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022). | Pharmaceuticals (Basel) | 2023 | 37631077 | PubTator, text mining | PubMed |
| An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments. | Int J Mol Sci | 2023 | 37628772 | PubTator, text mining | PubMed |
| Bioavailability Assessment of an Iron Formulation Using Differentiated Human Intestinal Caco-2 Cells. | Foods | 2023 | 37628015 | PubTator, text mining | PubMed |
| Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications. | Pharmacy (Basel) | 2023 | 37624085 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions: Research Methods and Applications. | Metabolites | 2023 | 37623842 | PubTator, text mining | PubMed |
| Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases. | Toxicol In Vitro | 2023 | 37597759 | PubTator, text mining | PubMed |
| OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides. | Nucleic Acid Ther | 2023 | 37590469 | PubTator, text mining | PubMed |
| Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study. | Curr Res Toxicol | 2023 | 37575337 | PubTator, text mining | PubMed |
| Hepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases. | Toxicol Appl Pharmacol | 2023 | 37574147 | PubTator, text mining | PubMed |
| Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics. | Molecules | 2023 | 37570873 | PubTator, text mining | PubMed |
| The Potential of Bile Acids as Biomarkers for Metabolic Disorders. | Int J Mol Sci | 2023 | 37569498 | PubTator, text mining | PubMed |
| SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients. | BMC Endocr Disord | 2023 | 37563580 | PubTator, text mining | PubMed |
| Relationship between testosterone and male bladder cancer. | Sci Rep | 2023 | 37553380 | PubTator, text mining | PubMed |
| A Comprehensive Evaluation of the Effects of RNA-Editing Proteins ADAR and ADARB1 on the Expression of the Drug-Metabolizing Enzymes in HepaRG Cells. | Drug Metab Dispos | 2023 | 37532539 | PubTator, text mining | PubMed |
| Modulation of immunity by tryptophan microbial metabolites. | Front Nutr | 2023 | 37521424 | PubTator, text mining | PubMed |
| Functionalization of Polyhydroxyalkanoates (PHA)-Based Bioplastic with Phloretin for Active Food Packaging: Characterization of Its Mechanical, Antioxidant, and Antimicrobial Activities. | Int J Mol Sci | 2023 | 37511387 | PubTator, text mining | PubMed |
| Metabolism and Chemical Degradation of New Antidiabetic Drugs (Part II): A Review of Analytical Approaches for Analysis of Gliptins. | Biomedicines | 2023 | 37509595 | PubTator, text mining | PubMed |
| Repurposing of Tibolone in Alzheimer's Disease. | Biomolecules | 2023 | 37509151 | PubTator, text mining | PubMed |
| Absorption, tissue distribution, and excretion of glycycoumarin, a major bioactive coumarin from Chinese licorice (Glycyrrhiza uralensis Fisch). | Front Pharmacol | 2023 | 37484020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/135152/papers?page=8